HTR7 and triple-negative breast carcinoma: Dandan Zhan’s study demonstrated that HTR7 expression was inhibited in invasive mixed breast carcinoma [20], whereas Venhar Cınar’s study revealed that HTR7 expression was increased in triple-negative breast cancer (TNBC) [7].